Related Experiment Videos
[Clinical studies in sultamicillin fine granule in the field of pediatrics]
1Department of Pediatrics, Ota General Hospital.
Insights
Sultamicillin (SBTPC) fine granule demonstrated high efficacy in treating pediatric bacterial infections, with a 96.7% success rate. This antibiotic showed effectiveness against various pathogens, making it a valuable option for pediatric care.
Area of Science:
- Pediatric infectious diseases
- Antibiotic therapy
- Clinical pharmacology
Context:
- Bacterial infections are a common concern in pediatric populations.
- Effective and safe antibiotic options are crucial for treating children.
- Sultamicillin (SBTPC) fine granule is a formulation for pediatric use.
Purpose:
- To evaluate the clinical efficacy and safety of sultamicillin (SBTPC) fine granule in pediatric patients.
- To assess the bacteriological eradication rates against common pediatric pathogens.
- To document the incidence of adverse events associated with SBTPC fine granule treatment.
Summary:
- A clinical study involved 30 pediatric patients with bacterial infections treated with SBTPC fine granule.
- An overall clinical efficacy rate of 96.7% was achieved (24 excellent, 5 good).
- Bacteriological eradication rates were 91.7% for Gram-positive cocci and 66.7% for Gram-negative rods. Common side effects included diarrhea (12.9%) and loose stools (16.1%).
Impact:
- SBTPC fine granule is confirmed as a useful therapeutic agent for pediatric bacterial infections.
- The study provides evidence supporting the use of SBTPC fine granule in pediatric clinical practice.
- Findings contribute to the understanding of SBTPC fine granule's efficacy and safety profile in children.
Abstract:
Clinical studies were carried out on sultamicillin (SBTPC) fine granule in the field of pediatrics. The results obtained are summarized below. 1. Thirty children with bacterial infections were treated with SBTPC fine granule. The clinical results were excellent in 24 and good in 5, with an efficacy rate of 96.7%. 2. Bacteriological screening identified 26 pathogenic organisms of which 14 were Gram-positive cocci and 12 Gram-negative rods. Eradication rates were 91.7% in Gram-positive cocci and 66.7% in Gram-negative rods. 3. As side effects, diarrhea was observed in 12.9%, loose stool in 16.1% and eosinophilia in 3.2% of the patients. From the above results, it appeared that SBTPC fine granule was a useful drug for treating bacterial infections in the field of pediatrics.